National Action Plan For The MHPSS Response To COVID-19

National Action Plan for the MHPSS Response to COVID-19

This action plan was developed as part of the national response to the COVID-19 outbreak. It aims at comprehensively addressing the MHPSS aspects of the COVID-19 outbreak in Lebanon for all persons living in the country. It was developed by the MOPH-National Mental Health Programme (NMHP) with WHO and UNICEF, in line with the IASC Briefing note on addressing mental health and psychosocial aspects of COVID-19 Outbreak- version 1.0 and the local needs, health system and national mental health strategy.

Goals:

Promote mental health and mitigate COVID-19 related stressors including stigma and discrimination against persons affected and health workers.
Provide mental health support to the persons in quarantine in the hospital or at home and their families.
Support the mental health of health workers and first responders in the response.
Ensure continuity of mental health care for persons using mental health services in line with IPC guidelines.

To view the action plan, click here: National Action Plan for MHPSS Response to COVID-19

...

All

ATC	Name	B/G	Ingredients	Dosage	Form ↓	Price
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	692,079 L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	291,614 L.L
A03CA02	BIPAX	G	Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg		Tablet, sugar coated	363,477 L.L
N07CA01	BETAHISTINE ARROW	G	Betahistine dihydrochloride - 16mg	16mg	Tablet, scored	362,837 L.L
N05BA08	BROMAZEPAM BIOGARAN	G	Bromazepam - 6mg	6mg	Tablet, scored	180,075 L.L
M01AC01	BREXIN	B	Piroxicam-?-cyclodextrin - 20mg	20mg	Tablet, scored	487,815 L.L
N04AA01	BENZHEXOL	G	Trihexyphenidyl - 5mg	5mg	Tablet, scored	533,697 L.L
G04BD12	BETMIGA	B	Mirabegron - 50mg	50mg	Tablet, prolonged release	3,758,727 L.L
M01AE03	BI-PROFENID LP	B	Ketoprofen - 100mg	100mg	Tablet, prolonged release	392,402 L.L
A16AX	BICANORM	G	Sodium bicarbonate - 1000mg	1000mg	Tablet, gastroresistant	2,623,181 L.L
C07AB07	BISOPROLOL QUIVER LAB	G	Bisoprolol fumarate - 5mg	5mg	Tablet, film coated, scored	264,737 L.L
C07AB07	BISOPROLOL QUIVER LAB	G	Bisoprolol fumarate - 10mg	10mg	Tablet, film coated, scored	526,786 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,237,679 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,237,679 L.L
C09BA04	BI-PRETERAX ARGININE	B	Perindopril arginine - 5mg, Indapamide - 1.25mg		Tablet, film coated	452,875 L.L
C09BA04	BI-PRETERAX ARGININE	B	Perindopril arginine - 10mg, Indapamide - 2.5mg		Tablet, film coated	765,990 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	51,483,159 L.L
C02KX01	BOSENTAN ARROW	G	Bosentan (monohydrate) - 62.5mg	62.5mg	Tablet, film coated	51,483,159 L.L
M05BA06	BONVIVA	B	Ibandronic acid - 150mg	150mg	Tablet, film coated	1,265,900 L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	L.L
M05BA06	BONAFOR	G	Ibandronic acid (monosodium monohydrate) - 150mg	150mg	Tablet, film coated	383,955 L.L
J05AR20	BIKTARVY	B	Bictegravir - 50mg, Emtricitabine - 200mg, Tenofovir alafenamide - 25mg		Tablet, film coated	76,569,138 L.L
L02BB03	BICALUTAMIDE ACCORD	G	Bicalutamide - 50mg	50mg	Tablet, film coated	1,382,814 L.L
L02BB03	BICALUTAMIDE GP PHARM	G	Bicalutamide - 50mg	50mg	Tablet, film coated	1,306,215 L.L
L02BB03	BICAMIDE	G	Bicalutamide - 50mg	50mg	Tablet, film coated	1,451,753 L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	35,663,747 L.L
L01EA04	BOSULIF	B	Bosutinib - 400mg	400mg	Tablet, film coated	123,564,667 L.L
L01EA04	BOSULIF	B	Bosutinib - 500mg	500mg	Tablet, film coated	154,453,246 L.L

...